CD74, HLA-DR, and TAP2 were expressed at significantly higher levels in the epithelium of cancer cells derived from tumors of patients with low- versus high-volume ascites (Figure 2; P = 0.046, P = 0.006, and P = 0.002, resp). The gene discussed is TAP2; the disease is cancer.